Third generation oral contraceptives. Full description of controls is needed in study

Comment

P Sasieni. BMJ. 1996.

. 1996 Mar 2;312(7030):577-8.

doi: 10.1136/bmj.312.7030.577b.

No abstract available

Comment on

Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women.
Spitzer WO, Lewis MA, Heinemann LA, Thorogood M, MacRae KD. Spitzer WO, et al. BMJ. 1996 Jan 13;312(7023):83-8. doi: 10.1136/bmj.312.7023.83. BMJ. 1996. PMID: 8555935 Free PMC article. Clinical Trial.
Third generation oral contraceptives and risk of myocardial infarction: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women.
Lewis MA, Spitzer WO, Heinemann LA, MacRae KD, Bruppacher R, Thorogood M. Lewis MA, et al. BMJ. 1996 Jan 13;312(7023):88-90. doi: 10.1136/bmj.312.7023.88. BMJ. 1996. PMID: 8555936 Free PMC article. Clinical Trial.